HELIX BIOTECH
Live / Applied — Suspended — suspension check completed, case still suspended (as of 20 Aug 2025)
What this means for you
Not registered yet, but its 13 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97792209
- Mark type
- Design + words
- Filed
- 13 Feb 2023
- Attorney of record
- Wade R. Orr
Goods and services
- Class 042 — Scientific and technological services: Chemical analysis; Chemical analysis services; Chemical research and analysis; Chemical, biochemical, biological and bacteriological research and analysis; Clinical research in the field of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product development; Product development and engineering services for others; Product development consultation; Product development consulting in the field of Lipid Nanoparticles (LNPs) and Liposome Samples. LNP and Liposome Formulation, Manufacturing, and Analytical Services; Product development for others; Product research and development; Basic and clinical research in the field of respiratory science and medicine; Consulting services for others in the field of design, planning, and implementation project management of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Consulting services in the field of product design and development; Design and testing for new product development; Executing of chemical analyses; Medical and scientific research, namely, conducting clinical trials for others; Performance of chemical analyses; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing information on clinical studies via an interactive website; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Testing, analysis and evaluation of leaf and petiole samples; Working on and evaluation of chemical analyses
Owner
- Helix Biotech, Inc, Knoxville, TN, US
Prosecution history
- 20 Aug 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 19 Aug 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 18 Feb 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 24 Jan 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 15 Apr 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 15 Apr 2024 — LETTER OF SUSPENSION E-MAILED
- 15 Apr 2024 — SUSPENSION LETTER WRITTEN
- 12 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Feb 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Jan 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Jan 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Jan 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Nov 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Nov 2023 — NON-FINAL ACTION E-MAILED